NCT05203289View on ClinicalTrials.gov

A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

August 29, 2022

Study Completion Date

August 29, 2022

Conditions
Healthy
Interventions
DRUG

BI 695501 - higher concentration

BI 695501 - higher concentration

DRUG

BI 695501 - lower concentration

BI 695501 - lower concentration

Trial Locations (2)

33143

Miami Research Associates, Inc, Miami

65802

QPS MO, Springfield

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05203289 - A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection | Biotech Hunter | Biotech Hunter